BARCELONA -- A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory ...

Objective To determine distinct patterns of patients with autoimmune diseases harbouring anti-Ku antibodies and their respective prognosis.Methods Anti-Ku-positive patients were retrieved through four ...

uhn.ca Background/objectives The European League Against Rheumatism (EULAR)/American College of Rheumatology ... involvement statement SLE patient representatives were involved at every stage of the ...

In 2019, the European Alliance of Association of Rheumatology/American College of Rheumatology (EULAR/ACR) published updated criteria for SLE with similar sensitivity but higher specificity than the ...

Those with chronic conditions, such as systemic lupus erythematosus (SLE), may be particularly vulnerable to social isolation. In this qualitative study, we elicited lived experiences of older ...

Primary outcome was progression to SLE, as defined by the 2019 European League Against Rheumatism/American College of Rheumatology classification criteria. Mean follow-up was 7 years.

Credit: Getty Images The American College of Rheumatology has released a new ... at least every 6 to 12 months among patients with SLE without known kidney disease. When LN is suspected, a prompt ...

WASHINGTON — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) medications appear beneficial for people with systemic lupus erythematosus (SLE ... at the American College of Rheumatology ...

Objective The 2019 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria score (≥20 points) has ...

Subsequent analyses of additional secondary endpoints showed clinical improvements in the DZP group, including SLE Responder Index (SRI)-4 response, corticosteroid tapering, SLE Disease Activity ...

The results were shared during an oral, late-breaker presentation at ACR Convergence 2024, the American College of Rheumatology’s annual meeting ... clinical improvements in the DZP group, including ...

The American College of Rheumatology (ACR) 2024 Convergence has just concluded ... had the potential to treat and reset autoimmunity in SLE and found evidence of partial B cell recovery after just two ...